Anil Narasimha is the co-founder and CEO of Mekonos, a company developing a platform for universal delivery of molecules into cells. After receiving his bachelors degree from UC Berkeley, he completed his Ph.D. at UC San Diego working on the mechanisms of cell cycle control in cancer. He then completed a postdoctoral fellowship at Stanford University under Dr. Michael Snyder, working on applications for personalized medicine and next-generation sequencing.